期刊文献+

研究心脉隆注射液治疗慢性心力衰竭的临床效果

Research on Clinical Effect of Xinmailong Injection in Treatment of Chronic Heart Failure
下载PDF
导出
摘要 目的分析心脉隆注射液在治疗慢性心力衰竭的临床效果。方法在该次研究中选择2016年1月—2017年1月该院收治的70例慢性心力衰竭患者作为研究对象,随机分为甲组和乙组,每组35例患者,分别给予常规方式和心脉隆注射液治疗,治疗结束后对效果进行评价。结果在该次研究中对甲组和乙组的治疗效果对比,甲组总有效率为71.4%,乙组总有效率为91.4%,乙组的总有效率高于甲组,数据对比差异有统计学意义。对甲组和乙组的LVEF、中心静脉压、BNP对比,实践可知,治疗后,乙组的LVEF高于甲组,中心静脉压、BNP低甲组,乙组治疗后的LVEF、中心静脉压、BNP分别为(46.2±2.1)%、(8.1±0.1)mm Hg、(84.5±21.1)pg/m L,数值趋于正常。数据对比后差异有统计学意义(P<0.05)。结论对慢性心力衰竭患者采用心脉隆注射液治疗,其效果明显,患者对其满意率比较高,值得推广和应用。 Objective To analyze the clinical effect of xinmailong injection in treatment of chronic heart failure.Methods 70 cases of patients with chronic heart failure admitted and treated in our hospital from January 2016 to January 2017 were selected as the research objects and randomly divided into two groups with 35 cases in each,the two groups were respectively treated with routine treatment and xinmailong injection,and the effect was evaluated at the end of treatment.Results The total effective rate in the group A and in the group B was respectively 71.4%and 91.4%,and the index in the group B was higher than that in the group A,and the difference was obvious,the practice showed that the LVEF in the group B was higher than that in the group A,and the central venous pressure and BNP were lower than those in the group A,after treatment,the LVEF,central venous pressure,BNP in the group B after treatment were respectively(46.2±2.1)%,(8.1±0.1)mmHg,(84.5±21.1)pg/mL,and the values to be normal,and the differences were obvious after comparison with statistical significance(P<0.05).Conclusion The effect of xinmailong injection in treatment of chronic heart failure is obvious,and the satisfactory rate of patients is high,which is worth promotion and application.
作者 孔汛 KONG Xun(Department of Cardiology,Chongqing General Hospital of Nantong Mineral Company,Chongqing,400800 China)
出处 《系统医学》 2017年第14期31-33,共3页 Systems Medicine
关键词 心脉隆注射液 慢性心力衰竭 治疗效果 Xinmailong injection Chronic heart failure Treatment effect
  • 相关文献

参考文献9

二级参考文献70

  • 1易岂建.利钠肽与心力衰竭[J].儿科药学杂志,2007,13(2):4-6. 被引量:4
  • 2陈灏珠.实用内科学[M]10版[M].北京:人民卫生出版社,1997.835.
  • 3Mosterd A, Hoes AW. Clinical epidemioIogy of heart failure [ J ]. Heart ,2007,93 ( 9 ) : 1137 - 1146.
  • 4杨静,陈光辉,蒋博,等.心脉隆注射液治疗110例老年慢性心力衰竭患者的疗效观察[J].药物与临床,2012,9(14):93-94.
  • 5Weitzenblum E. Chronic cor pulmonale[J]. Heart, 2003,89 : 225 - 230.
  • 6Voelkel NF, Quaffe RA, Leinwand LA, et al. Right ventricular function and failure: Report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure[J]. Circulation,2006,114 :1883 - 1891.
  • 7Di Napoli D,Di Giovanni P, Gaeta MA, et al. Trimetazidine and re duction inmortality and hospitalization in patients with ischemie di lated cardiomyopathy a posthoc analysis of the villa Pinid’ Abruzzo Trimetazidine Trial[J]. J Cardiovasc Pharmacol,2007,50(5) :585 - 589.
  • 8严丰祥,张华明,李树楠.心脉隆对立体大鼠心脏的强心和增加冠脉流量的作用[J].大理医学院学报,1992,1(1):1-4.
  • 9柯元南.慢性心力衰竭诊治新进展[J1中哥全科医学,2007,10(6):433.
  • 10李树青.黄芪治疗缺血性心肌病的临床观察[J].l中国中西医结合杂志,1995,15(2):77-78.

共引文献150

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部